Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy

被引:137
作者
Santoro-Lopes, G
de Pinho, AMF
Harrison, LH
Schechter, M
机构
[1] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Prevent Med, Infect Dis Clin,AIDS Lab, BR-21941590 Rio De Janeiro, Brazil
[2] Univ Pittsburgh, Sch Med, Infect Dis Epidemiol Res Unit, Pittsburgh, PA USA
[3] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
关键词
D O I
10.1086/338641
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This observational study assessed the effect of combination antiretroviral therapy on the risk of tuberculosis among 255 patients with human immunodeficiency virus (HIV) infection and advanced immunodeficiency who were living in an area of Brazil with a high incidence of tuberculosis. The use of highly active antiretroviral therapy in regions with a high prevalence of coinfection with HIV and Mycobacterium tuberculosis may contribute a lower incidence of tuberculosis.
引用
收藏
页码:543 / 546
页数:4
相关论文
共 14 条
[1]   Concurrent infections and HIV pathogenesis [J].
Bentwich, Z ;
Maartens, G ;
Torten, D ;
Lal, AA ;
Lal, RB .
AIDS, 2000, 14 (14) :2071-2081
[2]   Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy [J].
Brodt, HR ;
Kamps, BS ;
Gute, P ;
Knupp, B ;
Staszewski, S ;
Helm, EB .
AIDS, 1997, 11 (14) :1731-1738
[3]   A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: Differences in study outcomes [J].
El-Sadr, WM ;
Perlman, DC ;
Denning, E ;
Matts, JP ;
Cohn, DL .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (04) :623-632
[4]   The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs [J].
Forrest, DM ;
Seminari, E ;
Hogg, RS ;
Yip, B ;
Raboud, J ;
Lawson, L ;
Phillips, P ;
Schechter, MT ;
O'Shaughnessy, MV ;
Montaner, JSG .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) :1379-1385
[5]   Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection [J].
Girardi, E ;
Antonucci, G ;
Vanacore, P ;
Libanore, M ;
Errante, I ;
Matteelli, A ;
Ippolito, G .
AIDS, 2000, 14 (13) :1985-1991
[6]   Hit HIV-1 hard, but only when necessary [J].
Harrington, M ;
Carpenter, CCJ .
LANCET, 2000, 355 (9221) :2147-2152
[7]   Restoration of cellular immunity against tuberculosis in patients coinfected with HIV-1 and tuberculosis with effective antiretroviral therapy: Assessment by determination of CD69 expression on T cells after tuberculin stimulation [J].
Hsieh, SM ;
Hung, CC ;
Pan, SC ;
Wang, JT ;
Tsai, HC ;
Chen, MY ;
Chang, SC .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (03) :212-220
[8]  
Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026
[9]   AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy - The Swiss HIV Cohort Study [J].
Ledergerber, B ;
Erard, V ;
Weber, R ;
Hirschel, B ;
Furrer, H ;
Battegay, M ;
Vernazza, P ;
Bernasconi, E ;
Opravil, M ;
Kaufmann, D ;
Sudre, P ;
Francioli, P ;
Telenti, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (23) :2220-2226
[10]   Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J].
Palella, FJ ;
Delaney, KM ;
Moorman, AC ;
Loveless, MO ;
Fuhrer, J ;
Satten, GA ;
Aschman, DJ ;
Holmberg, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :853-860